HQ Function

Core research and development activities, particularly preclinical studies for its immunotherapy pipeline, along with corporate management and strategic planning.

Notable Features:

Situated in the Alexandria Center for Life Science, providing access to advanced laboratory facilities, shared amenities, and a vibrant ecosystem of peer biotech companies and research institutions.

Work Culture:

A dynamic, scientifically-driven environment characterized by intensive research, innovation, and collaboration, typical of early-stage biopharmaceutical ventures focused on breakthrough therapies.

HQ Significance:

The New York City location, specifically within a major life science cluster like the Alexandria Center, offers strategic advantages in talent acquisition, scientific collaboration, and proximity to financial markets and potential partners.

Values Reflected in HQ: The choice of a state-of-the-art research facility underscores a commitment to cutting-edge science, innovation, and excellence in drug discovery and development.

Location:

As a preclinical-stage biopharmaceutical company based in the United States, Innovimmune Biotherapeutics, Inc. primarily focuses its operations, including research and development, within the US. Its global presence at this stage is likely centered on scientific collaborations, participation in international conferences, and strategic planning for potential future global clinical trials and market entry.

Street Address:

430 E 29th St, Floor 9

City:

New York

State/Province:

New York

Country:

United States